Curis (CRIS) Income from Continuing Operations (2010 - 2026)

Curis (CRIS) reported Income from Continuing Operations of 11442000.0 for Q1 2026, down 7.78% on a YoY basis from 12407382.23 in Q1 2025, and down 159.11% quarter-over-quarter from 19356000.0 in Q4 2025.

Curis (CRIS) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Curis has reported Income from Continuing Operations for 17 years, with the latest figure at 11442000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations fell 7.78% year-over-year to 11442000.0; the trailing twelve-month figure through Mar 2026 stood at 8408000.0 (up 80.04% YoY), and the FY2025 full-year result was 7582000.0, up 82.53% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 11442000.0, down from 19356000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 19356000.0 in Q4 2025, with the low at 16109000.0 in Q1 2022.
  • Historically, Income from Continuing Operations has averaged 9794000.0 across 5 years, with a median of 11559000.0 in 2023.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 62.27% — and 2025, when it surged 301.25%.
  • Curis' Income from Continuing Operations stood at 11329000.0 in 2022, then declined by 3.38% to 11712000.0 in 2023, then grew by 17.88% to 9618000.0 in 2024, then surged by 301.25% to 19356000.0 in 2025, then sank by 159.11% to 11442000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 11442000.0 (Q1 2026), 19356000.0 (Q4 2025), and 7729000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -2.97 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -14.46 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -3.40 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.03 Bn
9 Abivax 95.45 Bn 95.45 Bn - -56.48 Mn
10 Curis 8.58 Mn -6.42 Mn - -11.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.44 Mn
Dec 31, 2025 19.36 Mn
Sep 30, 2025 -7.73 Mn
Jun 30, 2025 -8.59 Mn
Mar 31, 2025 -10.62 Mn
Dec 31, 2024 -9.62 Mn
Sep 30, 2024 -10.09 Mn
Jun 30, 2024 -11.80 Mn
Mar 31, 2024 -11.88 Mn
Dec 31, 2023 -11.71 Mn
Sep 30, 2023 -12.18 Mn
Jun 30, 2023 -11.96 Mn
Mar 31, 2023 -11.56 Mn
Dec 31, 2022 -11.33 Mn
Sep 30, 2022 -13.29 Mn
Jun 30, 2022 -15.94 Mn
Mar 31, 2022 -16.11 Mn
Dec 31, 2021 -13.62 Mn
Sep 30, 2021 -11.05 Mn
Jun 30, 2021 -11.73 Mn